Logo image of DNUT

KRISPY KREME INC (DNUT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:DNUT - US50101L1061 - Common Stock

4.34 USD
+0.05 (+1.17%)
Last: 12/8/2025, 8:04:23 PM
4.3213 USD
-0.02 (-0.43%)
After Hours: 12/8/2025, 8:04:23 PM
Fundamental Rating

1

Taking everything into account, DNUT scores 1 out of 10 in our fundamental rating. DNUT was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. DNUT may be in some trouble as it scores bad on both profitability and health. DNUT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year DNUT has reported negative net income.
In the past year DNUT had a positive cash flow from operations.
In the past 5 years DNUT reported 4 times negative net income.
Each year in the past 5 years DNUT had a positive operating cash flow.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of -19.63%, DNUT is doing worse than 93.89% of the companies in the same industry.
With a Return On Equity value of -76.15%, DNUT is not doing good in the industry: 65.65% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -19.63%
ROE -76.15%
ROIC N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

DNUT has a worse Gross Margin (28.67%) than 77.86% of its industry peers.
DNUT's Gross Margin has been stable in the last couple of years.
DNUT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

0

2. Health

2.1 Basic Checks

DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
DNUT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DNUT has been increased compared to 5 years ago.
Compared to 1 year ago, DNUT has a worse debt to assets ratio.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.18, we must say that DNUT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DNUT (0.18) is worse than 82.44% of its industry peers.
DNUT has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
DNUT has a Debt to Equity ratio (1.35) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 0.18
ROIC/WACCN/A
WACC7.76%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

DNUT has a Current Ratio of 0.36. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.36, DNUT is doing worse than 86.26% of the companies in the same industry.
A Quick Ratio of 0.30 indicates that DNUT may have some problems paying its short term obligations.
With a Quick ratio value of 0.30, DNUT is not doing good in the industry: 83.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.3
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

DNUT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -190.00%.
DNUT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.40%.
DNUT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.66% yearly.
EPS 1Y (TTM)-190%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-10.4%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-1.2%

3.2 Future

Based on estimates for the next years, DNUT will show a very negative growth in Earnings Per Share. The EPS will decrease by -14.87% on average per year.
The Revenue is expected to grow by 3.64% on average over the next years.
EPS Next Y-263.2%
EPS Next 2Y-70.32%
EPS Next 3Y-41.31%
EPS Next 5Y-14.87%
Revenue Next Year-8.78%
Revenue Next 2Y-4.12%
Revenue Next 3Y-1.41%
Revenue Next 5Y3.64%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2030 0 0.2 0.4

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DNUT. In the last year negative earnings were reported.
Also next year DNUT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DNUT is valued a bit more expensive than 74.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.76
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

DNUT's earnings are expected to decrease with -41.31% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-70.32%
EPS Next 3Y-41.31%

4

5. Dividend

5.1 Amount

DNUT has a Yearly Dividend Yield of 3.32%.
DNUT's Dividend Yield is rather good when compared to the industry average which is at 3.84. DNUT pays more dividend than 89.31% of the companies in the same industry.
DNUT's Dividend Yield is a higher than the S&P500 average which is at 2.31.
Industry RankSector Rank
Dividend Yield 3.32%

5.2 History

DNUT has been paying a dividend for over 5 years, so it has already some track record.
DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

The earnings of DNUT are negative and hence is the payout ratio. DNUT will probably not be able to sustain this dividend level.
DP-3.5%
EPS Next 2Y-70.32%
EPS Next 3Y-41.31%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

KRISPY KREME INC

NASDAQ:DNUT (12/8/2025, 8:04:23 PM)

After market: 4.3213 -0.02 (-0.43%)

4.34

+0.05 (+1.17%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-23 2026-02-23/bmo
Inst Owners43.81%
Inst Owner Change-2.15%
Ins Owners3.64%
Ins Owner Change1.76%
Market Cap743.44M
Revenue(TTM)1.53B
Net Income(TTM)-510.43M
Analysts54.67
Price Target4.36 (0.46%)
Short Float %34.99%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield 3.32%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP-3.5%
Div Incr Years0
Div Non Decr Years3
Ex-Date04-23 2025-04-23 (0.035)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-117.45%
Min EPS beat(2)-353.46%
Max EPS beat(2)118.57%
EPS beat(4)1
Avg EPS beat(4)-81.52%
Min EPS beat(4)-353.46%
Max EPS beat(4)118.57%
EPS beat(8)2
Avg EPS beat(8)-67.78%
EPS beat(12)5
Avg EPS beat(12)-46.53%
EPS beat(16)6
Avg EPS beat(16)-38.2%
Revenue beat(2)0
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-4.66%
Max Revenue beat(4)-1.53%
Revenue beat(8)1
Avg Revenue beat(8)-1.98%
Revenue beat(12)3
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.39%
PT rev (1m)2.24%
PT rev (3m)-3.52%
EPS NQ rev (1m)720.42%
EPS NQ rev (3m)1389%
EPS NY rev (1m)20%
EPS NY rev (3m)22.42%
Revenue NQ rev (1m)1.01%
Revenue NQ rev (3m)-2.49%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF 46.61
P/B 1.11
P/tB N/A
EV/EBITDA 22.76
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)0.09
OCFY2.15%
SpS8.96
BVpS3.91
TBVpS-4.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.63%
ROE -76.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.67%
FCFM N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 12.25
Cap/Depr 83.67%
Cap/Sales 7.48%
Interest Coverage N/A
Cash Conversion 21.56%
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.3
Altman-Z 0.18
F-Score5
WACC7.76%
ROIC/WACCN/A
Cap/Depr(3y)96.05%
Cap/Depr(5y)105.48%
Cap/Sales(3y)7.25%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-190%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y-263.2%
EPS Next 2Y-70.32%
EPS Next 3Y-41.31%
EPS Next 5Y-14.87%
Revenue 1Y (TTM)-10.4%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-1.2%
Revenue Next Year-8.78%
Revenue Next 2Y-4.12%
Revenue Next 3Y-1.41%
Revenue Next 5Y3.64%
EBIT growth 1Y-1143.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year481.25%
EBIT Next 3Y88.85%
EBIT Next 5Y57.43%
FCF growth 1Y-709.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.9%
OCF growth 3Y-31.28%
OCF growth 5Y-10.72%

KRISPY KREME INC / DNUT FAQ

What is the ChartMill fundamental rating of KRISPY KREME INC (DNUT) stock?

ChartMill assigns a fundamental rating of 1 / 10 to DNUT.


What is the valuation status for DNUT stock?

ChartMill assigns a valuation rating of 0 / 10 to KRISPY KREME INC (DNUT). This can be considered as Overvalued.


Can you provide the profitability details for KRISPY KREME INC?

KRISPY KREME INC (DNUT) has a profitability rating of 1 / 10.


What is the expected EPS growth for KRISPY KREME INC (DNUT) stock?

The Earnings per Share (EPS) of KRISPY KREME INC (DNUT) is expected to decline by -263.2% in the next year.


How sustainable is the dividend of KRISPY KREME INC (DNUT) stock?

The dividend rating of KRISPY KREME INC (DNUT) is 4 / 10 and the dividend payout ratio is -3.5%.